Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel nitric oxide synthase inhibitors developed for the prevention of cerebral palsy

March 17, 2009

Edluar receives FDA approval for insomnia

March 16, 2009

Yakult Honsha claims novel gamma-secretase inhibitors

March 16, 2009

Nippon Chemiphar presents novel P2X4 receptor antagonists

March 16, 2009

Dainippon launches Trerief in Japan for Parkinson's disease

March 16, 2009

Auris Medical initiates phase IIb AM-101 trial in acute inner ear tinnitus

March 16, 2009

Mechanism of action, activity of the coumarin scopoletin described

March 16, 2009

Coeloglossum viride extract protective in models of brain ischemia

March 16, 2009

GPR3 identified as a new pharmacological target for Alzheimer's disease

March 16, 2009

Novartis presents novel GABA-A receptor ligands

March 13, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...